Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 133.50
+4.00 (3.09%)
Oct 21, 2026, 1:30 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 21.7 billion as of October 20, 2026. It is the 12,786th most valuable company in the world and the 418th biggest in Taiwan. Its market cap has increased by 6.00% in one year.
Market Cap
21.70B
Enterprise Value
18.01B
Revenue
1.21B
Global Rank
Country Rank
#418 Taiwan
PE Ratio
42.90
ChartMarket Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 21.70B, an increase of 160.82%. That is a compound annual growth rate of 10.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 21.70B | 60.36% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 52.57B |
| Lotus Pharmaceutical | 47.20B |
| Center Laboratories | 23.65B |
| TTY Biopharm Company | 20.04B |
| Synmosa Biopharma | 15.91B |
| YungShin Global Holding | 15.69B |
| ScinoPharm Taiwan | 15.18B |
| Grape King Bio | 12.73B |